TC
NVO

Titleist Capital’s Novo Nordisk NVO Stock Holding History

Titleist Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$516K Buy
7,626
+332
+5% +$19.5K 0.12% 137
2022
Q3 		$363K Sell
7,294
-458
-6% -$24.5K 0.08% 155
2022
Q2 		$432K Buy
7,752
+542
+8% +$30.1K 0.11% 153
2022
Q1 		$400K Buy
7,210
+1,028
+17% +$52.8K 0.08% 168
2021
Q4 		$346K Buy
+6,182
New +$335K 0.07% 170

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Titleist Capital's NVO Position: Q4 2022 in Review

Titleist Capital increased its Novo Nordisk (NVO) stake by 4.6% in Q4 2022, buying an estimated $19.5K and bringing the position to 7,626 shares worth $516K. The position accounts for 0.12% of the portfolio, ranked #137.

Titleist Capital first reported a position in NVO in Q4 2021 and has held it in 5 quarters since. 1,050 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Titleist Capital held 7,626 shares of Novo Nordisk worth $516K as of Q4 2022.
  • Titleist Capital bought 332 Novo Nordisk shares in Q4 2022, an estimated $19.5K.
  • Novo Nordisk made up 0.12% of Titleist Capital's portfolio in Q4 2022, its #137 holding.
  • Titleist Capital first reported a position in Novo Nordisk in Q4 2021 and has held it in 5 quarters since.
  • 1,050 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.